Intrinsic Value of S&P & Nasdaq Contact Us

Zura Bio Limited ZURA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
60/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+162.2%

Stock Statistics — ZURA

Zura Bio Limited (ZURA) has a market capitalization of $371.93M and trades at $5.72. The 52-week range is 0.98-7.44.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.4, Earnings Per Share (EPS) of $-1.06.

The stock has a beta of 0.24, operates in the Healthcare sector.

Trading Data
Current Price$5.72
52-Week Range0.98-7.44
Volume644.54K
Avg Volume (30D)665.6K
Market Cap$371.93M
Beta (1Y)0.24
Company
IPO Date2023-03-21
Employees30
CEOSandeep C. Kulkarni
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINKYG9TY5A1016
Income (Latest Year)
Gross Profit$-49K
EBITDA$-75.25M
Operating Income$-75.25M
Net Income$-99.35M
EPS$-1.06
EPS Diluted$-1.06
Shares Outstanding$94.16M
Balance Sheet (Latest Year)
Total Assets$113.95M
Current Assets$112.31M
Cash & ST Investments$109.41M
Total Liabilities$12.41M
Net Debt$-109.41M
Total Equity$101.54M
Valuation Ratios
P/E Ratio-5.4
P/B Ratio3.66
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message